 | Up a level |
Aeppli, S; Schmaus, M; Eisen, T; Escudier, B; Grünwald, V; Larkin, J; McDermott, D; Oldenburg, J; Porta, C; Rini, B I; Schmidinger, M; Sternberg, C N; Rothermundt, C; Putora, P.M. (2021). First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts. ESMO open, 6(1), p. 100030. BMJ 10.1016/j.esmoop.2020.100030
Rothermundt, C; von Rappard, J; Eisen, T; Escudier, B; Grünwald, V; Larkin, J; McDermott, D; Oldenburg, J; Porta, C; Rini, B; Schmidinger, M; Sternberg, C N; Putora, Paul Martin (2017). Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms. World journal of urology, 35(4), pp. 641-648. Springer 10.1007/s00345-016-1903-6
Eisen, T; Sternberg, C; Robert, C; Mulders, P; Pyle, L; Zbinden, S; Izzedine, H; Escudier, B (2012). Targeted therapies for renal cell carcinoma: review of adverse event management strategies. Journal of the National Cancer Institute JNCI, 104(2), pp. 93-113. Cary, N.C.: Oxford University Press 10.1093/jnci/djr511
